MedTrace Logo

Study for the Use Smartphone Application to Prevent Suicidal Relapse Among 15-35 Years-old With Previous Suicide Attempted

NCT03975881 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-06-05

No results posted yet for this study

Summary

Context: Suicide is the 2nd cause of death during adolescence Compliance with post SA care is low and variable with effective compliance ranging from 17.5% to 47% . Therefore, prevention programs should also focus on high-risk individuals with a previous history of SA.

Adolescents and young adults are considered to be digital natives, they are therefore a relevant population for the testing of Smartphone Application.

Project: The Investigators propose an innovative and new approach to prevent SA and Suicide for patients, based on a mobile healthcare application.

The program is an add-on to the usual care process.

Study: In a multicentric randomized pilot study with 15 to 35 years-old patients having previous SA, the primary goal for pilot study is to observe the filling rate of the application (feasibility).

Conditions

  • Suicide Attempt by Scalding

Interventions

OTHER

application on smartphone

The aim of this study is to test the feasibility of our approach of preventing suicide relapse with the use of a smartphone application.

Sponsors & Collaborators

  • University Hospital, Angers

    collaborator OTHER_GOV

  • Rennes University Hospital

    collaborator OTHER

  • Saint Antoine University Hospital

    collaborator OTHER

  • Université de Nantes

    collaborator OTHER

  • Poitiers University Hospital

    collaborator OTHER

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Fanny GOLLIER BRIANT · Nantes University Hospital

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-12-01
Completion
2020-12-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03975881 on ClinicalTrials.gov